SELLAS Life Sciences - Clinical Biopharmaceutical Company
Late-stage clinical biopharmaceutical company developing novel cancer immunotherapies targeting unmet medical needs.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2025
Jan 2024
Jan 2023
Jan 2019
Mar 2018
Dec 2017
Create a free account to see which investors have funded this company.
Create Free Account
BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...
Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.
Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...
Research-based development stage biopharmaceutical company that discovers and develops innovative...

Clinical-stage biopharmaceutical company developing T cell receptor-based adoptive cell therapies...